1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow XC221 60 mg: new trials by email Literature Review of XC221 60 mg trials Research Report on XC221 60 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers XC221 60 mg, XC221 200 mg, Placebo - Influenza, Acute Respiratory Infection | Phase 1 | Completed | PHARMENTERPRISES LLC | 32 | 2017-05-22 | 2018-03-08 |
Influenza, Human (1)
Russia (1)